The U.S. researchers said the results justify larger clinical trials to evaluate this class of drugs known as glucagon-like peptide 1 (GLP-1) receptor agonists for alcohol use disorder. The study is … [+785 chars]Read More
Ozempic cut heavy drinking in clinical study POLITICO Europe
